Objective: Nateglinide (NTG) is a potent short-acting biopharmaceutical classification system class II antidiabetic medication. The primary objective of the present investigation was to prepare and evaluate solid dispersions of NTG to enhance the component solubility and immediate release (IR) profile. The secondary objective was to formulate sustained release (SR) matrix layer of NTG for prolonging its effect in the body and to decrease oscillations in plasma concentration level.Methods: NTG (270 mg) SR layer was formulated using release retardant polymers such as Carbopol, ethyl cellulose (EC), hydroxy EC, hydroxypropyl methylcellulose (HPMC), Kollidon, and locust bean gum at concentrations of 15% and 30%. IR layer of NTG (60 mg) was ...
The objective of this work was to prepare and evaluate oral sustained release matrix tablet of Nateg...
The objective of this work was to prepare and evaluate oral sustained release matrix tablet of Nateg...
For treating diabetes, it has been considered important that both a post prandial blood glucose leve...
Objective: Nateglinide is a commonly used oral hypoglycemic, biopharmaceutical classification system...
Nateglinide is an oral antidiabetic agent that should be administered 10-30min before the meal, but ...
AbstractThe aim of this study was to characterize the provesicle formulation of nateglinide (NTG) to...
  Objective: The main objective of this work is to develop new formulation to enhance the solubili...
The aim of present study is to formulate and evaluate extended release matrix tablet of Nateglinide ...
Nateglinide is a non-sulphonylurea insulinotropic oral antidiabetic agent. The main problem in formu...
Objective: The purpose of the present study was to develop an oral push-pull osmotic drug delivery s...
Nateglinide is a non-sulphonylurea insulinotropic oral antidiabetic agent. The main problem in formu...
The purpose of this research work was to formulate and evaluate the sustained release tablets of Nat...
The objective of this work was to prepare and evaluate oral sustained release matrix tablet of Nateg...
The objective of this work was to prepare and evaluate oral sustained release matrix tablet of Nateg...
AbstractThe aim of this study was to characterize the provesicle formulation of nateglinide (NTG) to...
The objective of this work was to prepare and evaluate oral sustained release matrix tablet of Nateg...
The objective of this work was to prepare and evaluate oral sustained release matrix tablet of Nateg...
For treating diabetes, it has been considered important that both a post prandial blood glucose leve...
Objective: Nateglinide is a commonly used oral hypoglycemic, biopharmaceutical classification system...
Nateglinide is an oral antidiabetic agent that should be administered 10-30min before the meal, but ...
AbstractThe aim of this study was to characterize the provesicle formulation of nateglinide (NTG) to...
  Objective: The main objective of this work is to develop new formulation to enhance the solubili...
The aim of present study is to formulate and evaluate extended release matrix tablet of Nateglinide ...
Nateglinide is a non-sulphonylurea insulinotropic oral antidiabetic agent. The main problem in formu...
Objective: The purpose of the present study was to develop an oral push-pull osmotic drug delivery s...
Nateglinide is a non-sulphonylurea insulinotropic oral antidiabetic agent. The main problem in formu...
The purpose of this research work was to formulate and evaluate the sustained release tablets of Nat...
The objective of this work was to prepare and evaluate oral sustained release matrix tablet of Nateg...
The objective of this work was to prepare and evaluate oral sustained release matrix tablet of Nateg...
AbstractThe aim of this study was to characterize the provesicle formulation of nateglinide (NTG) to...
The objective of this work was to prepare and evaluate oral sustained release matrix tablet of Nateg...
The objective of this work was to prepare and evaluate oral sustained release matrix tablet of Nateg...
For treating diabetes, it has been considered important that both a post prandial blood glucose leve...